Clinical presentation and outcome of toxoplasmic encephalitis in patients with human immunodeficiency virus type 1 infection

Journal of Microbiology, Immunology and Infection

Volumn 41, Issue 5, 2008, Pages 386-392

  Ho, Ya Chi ^a   Sun, Hsin Yun ^a   Chen, Mao Yuan ^a   Hsieh, Szu Min ^a   Sheng, Wang Huei ^a   Chang, Shan Chwen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Acquired immunodeficiency syndrome; Encephalitis; HIV; Mortality; Risk factors; Toxoplasmosis

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; DAPSONE; PYRIMETHAMINE; VIRUS RNA;

ADULT; ARTICLE; BASAL GANGLION; BRAIN CORTEX; BRAIN RADIOGRAPHY; BRAIN STEM; CD4+ T LYMPHOCYTE; CEREBELLUM; CLINICAL ARTICLE; COGNITIVE DEFECT; FEMALE; FEVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNE DEFICIENCY; INCIDENCE; INFECTIOUS COMPLICATION; LYMPHOCYTE COUNT; MALE; MEDICAL RECORD; MENTAL DEFICIENCY; MENTAL HEALTH; MORTALITY; NEUROLOGIC DISEASE; SEROLOGY; TAIWAN; TOXOPLASMIC ENCEPHALITIS; TREATMENT RESPONSE; VIRUS LOAD;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIPROTOZOAL AGENTS; ENCEPHALITIS; FEMALE; HIV-1; HUMANS; IMMUNOCOMPROMISED HOST; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MORTALITY; PROGNOSIS; RISK FACTORS; STATISTICS, NONPARAMETRIC; TAIWAN; TOXOPLASMOSIS, CEREBRAL;

EID: 60249087575     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis. 1992;15:211-22.
2. Oksenhendler E, Charreau I, Tournerie C, Azihary M, Carbon C, Aboulker JP. Toxoplasma gondii infection in advanced HIV infection. AIDS. 1994;8:483-7.
3. Fan CK, Su KE, Wu GH, Chiou HY. Seroepidemiology of Toxoplasma gondii infection among two mountain aboriginal populations and Southeast Asian laborers in Taiwan. J Parasitol. 2002;88:411-4.
4. Yu JC. A seroepidemiological study on Toxoplasma gondii infection among pregnant women and neonates in Taiwan. Taiwan Yi Xue Hui Za Zhi. 1985;84:286-95. [Article in Chinese].
5. Cross JH, Hsu HM. Seroepidemiology of toxoplasmosis on Taiwan and some of the offshore islands. Gaoxiong Yi Xue Ke Xue Za Zhi. 1989;5:493-7.
6. Bacellar H, Muñoz A, Miller EN, Cohen BA, Besley D, Seines OA, et al. Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985-1992. Neurology. 1994;44:1892-900.
7. Belanger F, Derouin F, Grangeot-Keros L, Meyer L. Incidence and risk factors of toxoplasmosis in a cohort of human immunodeficiency virus-infected patients: 1988-1995. HEMOCO and SEROCO Study Groups. Clin Infect Dis. 1999;28:575-81.
8. Hung CC, Chen MY, Hsieh SM, Hsiao CF, Sheng WH, Chang SC. Prevalence of Toxoplasma gondii infection and incidence of toxoplasma encephalitis in non-haemophiliac HIV-1-infected adults in Taiwan. Int J STD AIDS. 2005;16:302-6.
9. Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Seines OA, Miller EN, et al; Multicenter AIDS Cohort Study. HIV-associated neurologic disease incidence changes - Multicenter AIDS Cohort Study, 1990-1998. Neurology. 2001;56:257-60.
10. Ammassari A, Cingolani A, Pezzotti P, De Luca DA, Murri R, Giancola ML, et al. AIDS-related focal brain lesions in the era of highly active antiretroviral therapy. Neurology. 2000;55:1194-200.
11. Abgrall S, Rabaud C, Costagliola D; Clinical Epidemiology Group of the French Hospital Database on HIV. Incidence and risk factors for toxoplasmic encephalitis in human immunodeficiency virus-infected patients before and during the highly active antiretroviral therapy era. Clin Infect Dis. 2001;33:1747-55.
12. Antinori A, Larussa D, Cingolani A, Lorenzini P, Bos-solasco S, Finazzi MG, et al; Italian Registry Investigative NeuroAIDS. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy. Clin Infect Dis. 2004;39:1681-91.
13. Dedicoat M, Livesley N. Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings). Cochrane Database Syst Rev. 2006;3:CD005420.
14. Portegies P, Solod L, Cinque P, Chaudhuri A, Begovac J, Everall I, et al. Guidelines for the diagnosis and management of neurological complications of HIV infection. Eur J Neurol. 2004;11:297-304.
15. Sun HY, Chen MJ, Hung CC, Chen MY, Hsieh SM, Sheng WH, et al. Clinical presentations and virologic characteristics of primary human immunodeficiency virus type-1 infection in a university hospital in Taiwan. J Microbiol Immunol Infect. 2004;37:271-5.
16. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41(RR-17):1-19.
17. Sun HY, Chen MY, Hsieh SM, Sheng WH, Chang SY, Hsiao CF, et al. Changes in the clinical spectrum of opportunistic illnesses in persons with HIV infection in Taiwan in the era of highly active antiretroviral therapy. Jpn J Infect Dis. 2006;59:311-6.
18. Luft BJ, Hafner R, Korzun AH, Leport C, Antoniskis D, Bosler EM, et al. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team. N Engl J Med. 1993;329:995-1000.
19. Strittmatter C, Lang W, Wiestler OD, Kleihues P. The changing pattern of human immunodeficiency virus-associated cerebral toxoplasmosis: a study of 46 postmortem cases. Acta Neuropathol. 1992;83:475-81.
20. Post MJ, Sheldon JJ, Hensley GT, Soila K, Tobias JA, Chan JC, et al. Central nervous system disease in acquired immunodeficiency syndrome: prospective correlation using CT, MR imaging, and pathologic studies. Radiology. 1986;158:141-8.
21. Skiest DJ. Focal neurological disease in patients with acquired immunodeficiency syndrome. Clin Infect Dis. 2002;34:103-15.
22. Porter SB, Sande MA. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med. 1992;327:1643-8.
23. Modi M, Mochan A, Modi G. Management of HIV-associated focal brain lesions in developing countries. QJM. 2004;97:413-21.
24. Gildenberg PL, Gathe JC Jr, Kim JH. Stereotactic biopsy of cerebral lesions in AIDS. Clin Infect Dis. 2000;30:491-9.
25. Hornef MW, Iten A, Maeder P, Villemure JG, Regli L. Brain biopsy in patients with acquired immunodeficiency syndrome: diagnostic value, clinical performance, and survival time. Arch Intern Med. 1999;159:2590-6.
26. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004; 363:1965-76.
27. Masur H, Kaplan JE, Holmes KK; US Public Health Service; Infectious Diseases Society of America. Guidelines for preventing opportunistic infections among HIV-infected persons - 2002. Recommendations of the US Public Health Service and the Infectious Diseases Society of America. Ann Intern Med. 2002;137(5 Pt 2):435-78.
28. Bertschy S, Opravil M, Cavassini M, Bernasconi E, Schiffer V Schmid P, et al; Swiss HIV Cohort Study. Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to antiretroviral therapy. Clin Microbiol Infect. 2006;12:666-71.